Skip to content
Logo UroCCR fond blanc

News

Resources

Database
  • French
  • The Network
    • Presentation
    • Governance
  • Research projects
  • Medical devices
    • Presentation
    • Governance
  • UroPredict AI
  • Partners
  • Contact
  • News
  • Resources
  • Database
  • The Network
    • Presentation
    • Governance
  • Research projects
  • Medical devices
    • Presentation
    • Governance
  • UroPredict AI
  • Partners
  • Contact
  • News
  • Resources
  • Database
Contact

News

Resources

Database
  • The Network
    • Presentation
    • Governance
  • Research projects
  • Medical devices
    • Presentation
    • Governance
  • UroPredict AI
  • Partners
  • Contact
  • News
  • Resources
  • Database
  • The Network
    • Presentation
    • Governance
  • Research projects
  • Medical devices
    • Presentation
    • Governance
  • UroPredict AI
  • Partners
  • Contact
  • News
  • Resources
  • Database
Contact

Phase: Ongoing

Robot-assisted partial nephrectomy guided by 3D modeling for renal tumor with venous extension: characteristics, surgical strategies and outcomes from a single-center series.

Oligometastatic clear cell renal cell carcinoma: a retrospective multicenter study

Validation of a new classification for cT1 renal cell carcinomas

Survival of patients undergoing adrenalectomy for synchronous metastasis

Robotic Surgery for Cystic Renal Tumors: Impact of Preoperative 3D Modeling on Trifecta

Transcriptomic Analysis of advanced renal cell carcinoma to identify Key genomic signatures predicting clinical response to next-generation anti-VEGFR Therapy and dual Immune Checkpoint inhibition

Caractéristiques et devenir des patients traités par immunothérapie néoadjuvante pour cancer du rein localisé : étude rétrospective multicentrique

Survival in the context of renal replacement therapy after energy-based treatment or nephrectomy.

Corrélation entre paramètres radiomiques CT et IRM des carcinomes rénaux à cellules claires (ccCCR) et leur grade histologique : vers une prédiction non invasive de l’agressivité tumorale.

Évaluation de l’intégration de données synthétiques dans les essais cliniques randomisés : application à l’étude P-NeLoP

Next →
Cercle rouge UroCCR Bordeaux
Cercle bleu UroCCR Bordeaux
Logo UroCCR
  • Address

Department of Urology
Bordeaux University Hospital Centre
Place Amélie Raba-Léon 33076 Bordeaux cedex

  • Telephone │+33 05 57 82 12 94
  • E-MAIL │uroccr@chu-bordeaux.fr
  • FAX │+33 05 56 79 56 51
Linkedin-in Youtube X-twitter

Legal notices

Privacy policy

Copyright © 2026 UroCCR
  • French